Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Unknown 3Recruiting 3Not yet recruiting 2Active not recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Recurrence 2Multiple Myeloma 2Lymphoma 2Burkitt Lymphoma 2Pancreatic Neoplasms 1Neoplasms 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, B-Cell 1Leukemia 1Carcinoma, Pancreatic Ductal 1

Interventions

blinatumomab 2Immunotherapy, Adoptive 2pomalidomide 1Specimen Handling 1Interleukin 1 Receptor Antagonist Protein 1Inotuzumab Ozogamicin 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Burkitt Lymphoma × Immunotherapy, Adoptive × Clear all
NCT07043218 2025-06-29

A Clinical Study Exploring Universal CAR-T Cell in Patients With Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia

Shanghai Tongji Hospital, Tongji University School of Medicine

Phase 1 Not yet recruiting
36 enrolled
Lymphoid

Burkitt Lymphoma

NCT07020260 2025-06-13

PACMAN

Princess Maxima Center for Pediatric Oncology

Phase 1/2 Not yet recruiting
18 enrolled
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Leukemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡